AllianceBernstein’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

AllianceBernstein’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-211,520	Closed	-$5.1M	–	3527
2014 Q2	$5.1M	Buy	211,520 +38,700	+22%	+$403K	﹤0.01%	1129
2014 Q1	$1.04M	Sell	172,820 -8,700	-5%	-$60.7K	﹤0.01%	2148
2013 Q4	$1.08M	Buy	181,520 +1,651	+0.9%	+$7.64K	﹤0.01%	2110
2013 Q3	$937K	Buy	179,869 +4,078	+2%	+$17.9K	﹤0.01%	2159
2013 Q2	$635K	Buy	+175,791	New	+$719K	﹤0.01%	2340

AllianceBernstein's IDIX Position: Q3 2014 in Review

AllianceBernstein sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 211,520 shares — an estimated $5.1M sold.

AllianceBernstein first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $5.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

AllianceBernstein reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
AllianceBernstein sold 211,520 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $5.1M.
AllianceBernstein first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
AllianceBernstein's IDENIX PHARMACEUTICALS INC position peaked at $5.1M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on AllianceBernstein's 13F filing for Q3 2014, filed 13 Nov 2014.